Cas No.: | 95809-78-2 |
Chemical Name: | 6,8-Bis(benzylthio)octanoic acid |
Synonyms: | CPI-613;6,8-Bis(benzylthio)octanoic Acid;6,8-Bis(benzylsulfanyl)octanoic acid;CPI 613;OCTANOIC ACID, 6,8-BIS[(PHENYLMETHYL)THIO]-;6,8-Bis[(phenylmethyl)thio]octanoic acid;Devimistat;AK174899;Octanoic acid, 6,8-bis((phenylmethyl)thio)-;MLS006010202;AOB1058;HMS3656L06;C22H28O2S2;BCP04663;s2776;BCP9000552;DB12109;SMR004701300;BCP0726000030;AB0035874;SW2202 |
SMILES: | S(C([H])([H])C1C([H])=C([H])C([H])=C([H])C=1[H])C([H])(C([H])([H])C([H])([H])SC([H])([H])C1C([H])=C([H])C([H])=C([H])C=1[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(=O)O[H] |
Formula: | C22H28O2S2 |
M.Wt: | 388.5865 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | CPI-613 is a lipoic acid analog that inhibits pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase, disrupts mitochondrial metabolism and shows strong antitumor activity. |
References: | [1]. Zachar Z, Marecek J, Maturo C et al. Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo. J Mol Med (Berl). 2011 Nov;89(11):1137-48. [2]. Lee KC, Shorr R, Rodriguez R et al. Formation and anti-tumor activity of uncommon in vitro and in vivo metabolites of CPI-613, a novel anti-tumor compound that selectively alters tumor energy metabolism. Drug Metab Lett. 2011 Aug;5(3):163-82. [3]. Safety and Effectiveness Study of CPI-613 to Treat Refractory or Relapsed Leukemia and Myelodysplastic Syndrome |